Biosimulation Market Worth $2.88 Billion : Increase in R&D Investments in the Pharmaceutical and Biotechnology Industries
The Biosimulation Market is expected to reach USD 2.88 Billion by 2022 from USD 1.38 Billion in 2017, at a CAGR of 15.9%.
View full press release